RT Book, Section
A1 Christiansen, Sandy
A1 Freeman, Brian S.
A2 Freeman, Brian S.
A2 Berger, Jeffrey S.
SR Print(0)
ID 1135739000
T1 Antidepressant Drugs
T2 Anesthesiology Core Review: Part Two Advanced Exam
YR 2016
FD 2016
PB McGraw-Hill Education
PP New York, NY
SN 9781259641770
LK accessanesthesiology.mhmedical.com/content.aspx?aid=1135739000
RD 2024/04/24
AB Depression  is  commonly  encountered  in  the  general  population,  affecting  over  15%  of  people  at  some  point  during  their  lives.  Consequently,  the  prevalence  of  patients  taking  mood-altering  pharmaceuticals  is  significant.  These  medications  include  selective  serotonin  reuptake  inhibitors  (SSRI),  serotonin-norepinephrine  reuptake  inhibitors  (SNRI),  tricyclic  antidepressants  (TCA),  norepinephrine-dopamine  reuptake  inhibitors  (NDRI),  monoamine  oxidase  inhibitors  (MAOI),  and  atypical  antidepressants  (Table  28-1).  Each  of  these  classes  of  medications  present  unique  implications  for  the  anesthetic  management  of  the  patient  and  thus  it  is  essential  to  understand  the  mechanism  of  action,  side  effect  profile,  and  drug  interactions  of  each.